tirzepatide trade names Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research Tirzepatide (Zepbound, Mounjaro): Weight Loss,

The dose escalation journey: what each level feels like Understanding what to expect at each dose level helps you interpret your own before-and-after journey

5.5 Long-Term Suppression of Growth in Pediatric Patients VYVANSE is not approved for use and is not recommended in pediatric patients below 6 years of age [see Use in Specific Populations (8.4)]

Compounded semaglutide is not FDA approved and does not undergo the same rigorous efficacy and safety checks as do FDA-approved medications

This serves as a reminder of the importance of careful dose titration, structured dietary counseling, and proactive management of gastrointestinal symptoms in routine clinical practice

RECOVER focused on agents that already had some clinical support